Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
about
Treatment of metastatic colorectal cancer: focus on panitumumabImproved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy.Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.Circulating tumor cell technologies.Clinical and biological significance of circulating tumor cells in cancer.Plasticity of tumor cell invasion: governance by growth factors and cytokines.Liquid biopsies in gastrointestinal malignancies: when is the big day?MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.Classifying circulating tumor cells to monitor cancer progression.
P2860
Q27022954-C374B81C-8715-493B-AA53-4281953BA33FQ36018511-CB06738B-F356-4EF3-9EE2-10B68F2396D8Q37181546-C2DA8D5C-0746-422E-AC1A-6CB0DAACF6B2Q37709420-AFAFB641-4001-409B-9AE1-1CB69AC43B86Q38711439-81ECA010-9E5F-434B-AEED-7C7E11946F54Q38742272-1C0D73AD-63F8-437A-81D1-91E2D3E662B7Q38743200-79840686-9BF0-413F-9598-A828B9E95FBFQ38963431-199DAE51-937D-4A7F-8DA9-F42B3223051EQ47372761-7D9AD968-043E-42A3-A3E8-34D7E783C540Q50070846-BC1ADD12-14A0-4917-92D7-0443C0B3A7F2Q53755908-10281E68-6876-4AA4-82E9-C9049DDE3A84
P2860
Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@en
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@nl
type
label
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@en
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@nl
prefLabel
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@en
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@nl
P2093
P2860
P50
P921
P356
P1476
Circulating tumor cells as a l ...... ving cetuximab or panitumumab.
@en
P2093
Eleonora Di Buduo
Ilaria Bossi
Roberto Iacovelli
P2860
P304
P356
10.1002/IJC.29493
P50
P577
2015-03-04T00:00:00Z